CD56-positive cutaneous lymphoma: A poorly recognized entity in the spectrum of primary cutaneous disease

British Journal of Dermatology

Volumn 137, Issue 6, 1997, Pages 966-971

  Savoia, P ^a   Fierro, M T ^a   Novelli, M ^a   Quaglino, P ^a   Verrone, A ^a   Geuna, M ^a   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DISEASE COURSE; FOLLOW UP; GENOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SKIN LYMPHOMA; SOUTHERN BLOTTING;

EID: 0031434591     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01561.x     Document Type: Article

References (19)

1. Kern WF, Spier CM, Miller TP, Grogan MT. NCAM (CD56)-positive malignant lymphoma. Leuk Lymphoma 1993; 12: 1-10.
2. Wong KF, Chan JKC, Ng CS. CD56 (NCAM)-positive malignant lymphoma. Leuk Lymphoma 1994; 14: 29-36.
3. Nakamura S, Suchi T, Koshikawa T et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Sur Pathol 1993; 19: 284-96.
4. Kern WF, Spier CM, Hanneman EH et al. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992; 79: 2432-7.
5. Wong KF, Chan JKC, Ng CS et al. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Hum Pathol 1992; 23: 798-804.
6. Jaffe ES. Classification of natural killer (NK) and NK-like T-cell malignancies. Blood 1996; 87: 1207-10.
7. Adachi M, Maeda K, Takekawa M et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994; 47: 278-82.
8. Dummer R, Potoczna N, Haffner AC et al. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. Arch Dermatol 1996; 132: 550-3.
9. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361.
10. Novelli M, Fierro MT, Lisa F et al. Skin-infiltrating lymphocyte flow-cytometric immunophenotyping: automating mechanical biopsy disaggregation and CD45 gating. J Invest Dermatol 1996; 107: 501.
11. Maniatis T, Fritsch E, Sambrook I. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
12. Imamura N, Kusonoki Y, Kawa-Ha K et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol 1990; 75: 49-59.
13. Sun T, Brody J, Susin M et al. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity. Am J Surg Pathol 1993; 17: 1289-99.
14. Emile JF, Boulland ML, Haioun C et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466-73.
15. Dan S, Esumi M, Sawada U et al. Expression of a multidrug-resistance gene in human malignant lymphoma and related disorders. Leuk Res 1991; 15: 1139-43.
16. Pileri SA, Sabattini E, Falini B et al. Immunohistochemical detection of the multidrug transport protein p-170 in human normal tissues and malignant lymphomas. Histopathology 1991; 19: 131-40.
17. Biassoni R, Ferrini S, Prigione I et al. CD3-negative lymphokine-activated cytotoxic cells express the CD3 gene. J Immunol 1988; 140: 1685-9.
18. Cerroni L, Kerl H. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders. Dermatol Clin 1994; 12: 219-29.
19. Gerdes J. Ki-67 and other proliferative markers useful for immunohistochemical diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990; 1: 199-206.